Document Detail


In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin.
MedLine Citation:
PMID:  19407848     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the course of our screening for antitrypanosomal compounds from soil microorganisms, as well as from the antibiotics library of the Kitasato Institute for Life Sciences, we found three peptide antibiotics, leucinostatin (A and B), alamethicin I and tsushimycin, which exhibited potent or moderate antitrypanosomal activity. We report here the in vitro and in vivo antitrypanosomal properties and cytotoxicities of leucinostatin A and B, alamethicin I and tsushimycin compared with suramin. We also discuss their possible mode of action. This is the first report of in vitro and in vivo trypanocidal activity of leucinostatin A and B, alamethicin I and tsushimycin.
Authors:
Aki Ishiyama; Kazuhiko Otoguro; Masato Iwatsuki; Masahito Iwatsuki; Miyuki Namatame; Aki Nishihara; Kenichi Nonaka; Yuta Kinoshita; Yoko Takahashi; Rokuro Masuma; Kazuro Shiomi; Haruki Yamada; Satoshi Omura
Related Documents :
20656778 - Characterization of peptide deformylase homologues from staphylococcus epidermidis.
7275848 - Epithienamycins. ii. isolation and structure assignment.
6370248 - Microcin 7: purification and properties.
16484198 - Characterization of the bifunctional glycosyltransferase/acyltransferase penicillin-bin...
23576308 - A peptoid ribbon secondary structure.
795658 - Sequence studies on d-serine dehydratase of escherichia coli. primary structure of the ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-05-01
Journal Detail:
Title:  The Journal of antibiotics     Volume:  62     ISSN:  0021-8820     ISO Abbreviation:  J. Antibiot.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-26     Completed Date:  2009-10-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0151115     Medline TA:  J Antibiot (Tokyo)     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  303-8     Citation Subset:  IM    
Affiliation:
Research Center for Tropical Diseases, Center for Basic Research, Kitasato Institute for Life Sciences and Graduate School of Infectious Control Sciences, Kitasato University, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alamethicin / isolation & purification,  pharmacology*,  therapeutic use
Animals
Anti-Bacterial Agents / pharmacology*,  therapeutic use
Cell Line
Cell Survival / drug effects
Female
Fermentation
Lipopeptides / isolation & purification,  pharmacology*,  therapeutic use
Mice
Mice, Inbred ICR
Paecilomyces / classification,  metabolism*
Peptides / isolation & purification,  pharmacology*,  therapeutic use
Suramin / pharmacology
Trypanocidal Agents*
Trypanosoma brucei brucei / drug effects
Trypanosoma brucei rhodesiense / drug effects
Trypanosomiasis, African / drug therapy*,  parasitology
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Lipopeptides; 0/Peptides; 0/Trypanocidal Agents; 11054-63-0/tsushimycin; 145-63-1/Suramin; 27061-78-5/Alamethicin; 76600-38-9/leucinostatin A; 76663-52-0/leucinostatin B
Comments/Corrections
Erratum In:
J Antibiot (Tokyo). 2009 Jun;62(6):343
Note: Iwatsuki, Masahito [corrected to Iwatsuki, Masato]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surveillance of traumatic optic neuropathy in the UK.
Next Document:  RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic aden...